Associations Between Routine Blood‐Derived Inflammatory Markers and 14‐Day Readmission After Total Hip Arthroplasty: An Exploratory Study
Orthopaedic Surgery · 2026
DOI: 10.1111/os.70220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Orthopaedic Surgery, 2026. Verfasst von Ngi-Chiong Lau und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Chang Gung Memorial Hospital, Keelung Branch, Keelung, Taiwan, China. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Patient Readmission, Postoperative Complications. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
Early readmission following total hip arthroplasty ( THA ) is not uncommon and impacts patient outcomes and healthcare costs. However, easily accessible biomarkers for early identification of high‐risk patients remain limited. This study aims to evaluate the association between various blood component‐derived ratios and 14‐day readmission after THA .
Methods
Data from the Chang Gung Medical Research Database ( CGRD ) from 2014 to 2022 were retrospectively analyzed. Patients ≥ 20 years old who underwent primary THA by a single surgeon were included. The primary outcome was 14‐day readmission. Five hematologic markers were evaluated: monocyte‐to‐albumin ratio ( MAR ), red cell distribution width ( RDW )‐to‐albumin ratio ( RAR ), hemoglobin‐to‐albumin ratio ( HAR ), leukocyte‐to‐albumin ratio ( LAR ), and RDW ‐to‐platelet ratio ( RPR ). Ratios were calculated from blood collected within 1 month before to 1 week after surgery. Receiver operating characteristic ( ROC ) Curve analysis was used to determine their optimal thresholds, and multivariable logistic regression assessed associations between these markers and readmission risk.
Results
A total of 307 patients were included in the analysis. Among the ratios evaluated, only high RPR (≥ 0.10; aOR = 5.92, 95% CI : 2.19–16.00, p = 0.001) was significantly associated with increased risk of 14‐day readmission after adjustment in the multivariable analysis.
Conclusion
RPR is independently associated with 14‐day readmission following THA in this exploratory study. As an easily obtainable marker, it may aid postoperative risk stratification, and the findings provide a foundation for future multicenter prospective investigations incorporating more granular perioperative factors and additional biomarkers before clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Chang Gung Memorial Hospital, Keelung Branch, Keelung, Taiwan, China.
- College of Medicine, Chang Gung University, Taoyuan, Taiwan, China.
- Department of Orthopedic Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan, China.
- Biobank, Chang-Gung Memorial Hospital, Keelung, Taiwan, China.
ORCID-Profile: Dave W Chen
Zitieren
APA
Lau, N. C., Hu, C. C., Huang, Y. Y., Huang, P. R., & Chen, D. W. (2026). Associations Between Routine Blood‐Derived Inflammatory Markers and 14‐Day Readmission After Total Hip Arthroplasty: An Exploratory Study. Orthopaedic Surgery. https://doi.org/10.1111/os.70220
Vancouver
Lau NC, Hu CC, Huang YY, Huang PR, Chen DW. Associations Between Routine Blood‐Derived Inflammatory Markers and 14‐Day Readmission After Total Hip Arthroplasty: An Exploratory Study. Orthopaedic Surgery. 2026. doi:10.1111/os.70220
BibTeX
@article{Lau2026,
author = {Lau, Ngi-Chiong and Hu, Chih-Chien and Huang, Yu-Yi and Huang, Pin-Ren and Chen, Dave W},
title = {Associations Between Routine Blood‐Derived Inflammatory Markers and 14‐Day Readmission After Total Hip Arthroplasty: An Exploratory Study},
journal = {Orthopaedic Surgery},
year = {2026},
doi = {10.1111/os.70220}
}
EUVIMED